The InstituteThe Centro Nacional de Análisis Genómico (CNAG-CRG) is one of the largest Genome Sequencing Centers in Europe. CNAG-CRG researchers participate in major International Genomic Initiatives such as the International Cancer Genome Consortium (ICGC), the International Human Epigenome Consortium (IHEC), the International Rare Diseases Research Consortium (IRDiRC) and the European Infrastructure for life-science information (ELIXIR), as well as in several EU-funded projects. It is integrated with the Centre for Genomic Regulation (CRG), an international biomedical research institute of excellence, based in Barcelona, Spain, with more than 400 scientists from 44 countries. The CRG is composed of an interdisciplinary, motivated and creative scientific team which is supported both by a flexible and efficient administration and by high-end and innovative technologies. In April 2021, the Centre for Genomic Regulation (CRG) received the renewal of the 'HR Excellence in Research' logo from the European Commission. This is a recognition of the Institute's commitment to developing an HR Strategy for Researchers, designed to bring the practices and procedures in line with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers (Charter and Code).The RoleAbout the TeamThe CNAG-CRG, directed by Dr. Ivo Gut, aims to carry out large-scale projects in DNA/RNA sequence analysis for the improvement of quality of life in collaboration with the Spanish, European and International Research Community. The CNAG-CRG operates 7 Illumina and 4 Oxford Nanopore sequencing instruments together with an outstanding computing infrastructure (13 petabyte of data storage and 8000 cores of computing). The integrated CNAG-CRG infrastructure has one of the largest DNA sequencing capacities in Europe. The operation is certified ISO 9001 and accredited ISO 17025. Single-cell genomics and long-read sequencing are strategic priorities for CNAG-CRG, with dedicated laboratory teams. Dr. Ivo Gut participates in the European Union Horizon 2020 funded projects BCAST, SPIDIA-4P, ELIXIR-EXCELERATE, SOLVE-RD, EJP-RD, 3TR, ImmuCan, EuCanCan and Screen4Care. In addition, the CNAG-CRG participates in major Spanish initiatives in Personalized Medicine such as the PERIS projects MedPERCAN and URDCat, the 1,000 Catalan Genomes project, and the Navarra project on personalized medicine.Whom would we like to hire?Professional experienceMust Have- You are very experienced in methods development- You have experience in next generation sequencing technologiesDesirable but not required- You have experience in single-cell and long-read sequencing technologies (Oxford Nanopore Technologies).- You have experience in implementing lab standards and benchmarking procedures.Education and training- You hold a PhD in molecular biology with excellent understanding of laboratory techniques.Languages- You are fluent in English.Competences- You have highly developed organization skills.- You are proactive.- You are a team player.The Offer- Contract duration: 1 year with the possibility of extension.- Estimated annual gross salary: Salary is commensurate with qualifications and consistent with our pay scales. We provide a highly stimulating environment with state-of-the-art infrastructures, and unique professional career development opportunities.We offer and promote a diverse and inclusive environment and welcome applicants regardless of age, disability, gender, nationality, ethnicity, religion, sexual orientation or gender identity. The CRG is committed to reconciling work and family life of its employees and is offering an extended vacation period and the possibility to benefit from flexible working hours.
#J-18808-Ljbffr
